Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.55 is 295% above its 5-year average of 0.64, near the high end of its 5-year range (0.00–2.55).
As of the fiscal period ended Tuesday, June 30, 2026. 15.86% above its 12-month average of 2.20.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 2.55.
QUICK RATIO (ACID-TEST)
2.55
QUICK RATIO (ACID-TEST) AVG TTM
2.20
QUICK RATIO (ACID-TEST) AVG 3Y
1.03
QUICK RATIO (ACID-TEST) AVG 5Y
0.64
QUICK RATIO (ACID-TEST) AVG 10Y
0.03
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.86%
CURRENT VS 3Y AVG
+147.79%
CURRENT VS 5Y AVG
+295.29%
CURRENT VS 10Y AVG
+9902.74%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-23.98%
vs the sector median at left
Propanc Biopharma, Inc.
Market Cap
$1.14M
Quick Ratio (Acid-Test)
2.55
TTM Avg
2.20
3Y Avg
1.03
5Y Avg
0.64
Market Cap
$1.13M
Quick Ratio (Acid-Test)
0.46
TTM Avg
0.56
3Y Avg
0.51
5Y Avg
1.01
Market Cap
$1.11M
Quick Ratio (Acid-Test)
3.75
TTM Avg
3.27
3Y Avg
2.43
5Y Avg
2.43
Market Cap
$1.07M
Quick Ratio (Acid-Test)
4.31
TTM Avg
1.47
3Y Avg
1.08
5Y Avg
7.17
Market Cap
$1.02M
Quick Ratio (Acid-Test)
7.81
TTM Avg
0.12
3Y Avg
1.01
5Y Avg
1.01
Market Cap
$1.34M
Quick Ratio (Acid-Test)
3.00
TTM Avg
0.80
3Y Avg
7.12
5Y Avg
9.62
Market Cap
$905892.00
Quick Ratio (Acid-Test)
0.46
TTM Avg
3.06
3Y Avg
2.92
5Y Avg
4.33
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | $1.14M | 2.55 | 2.20 | 1.03 | 0.64 |
| IM Cannabis Corp. (IMCC)vs › | $1.13M | 0.46 | 0.56 | 0.51 | 1.01 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 3.75 | 3.27 | 2.43 | 2.43 |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 4.31 | 1.47 | 1.08 | 7.17 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 7.81 | 0.12 | 1.01 | 1.01 |
| Genprex, Inc. (GNPX)vs › | $1.34M | 6.77 | 2.33 | 3.65 | 16.80 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | 3.00 | 0.80 | 7.12 | 9.62 |
| NewcelX Ltd. (NCEL)vs › | $1.37M | 0.32 | 1.73 | 1.61 | 1.48 |
| GlucoTrack, Inc. (GCTK)vs › | $905892.00 | 0.46 | 3.06 | 2.92 | 4.33 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.41M | 0.62 | 1.47 | 0.74 | 0.53 |
Quick Ratio
2.55
Excludes inventory
Current Ratio
2.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.55 |
| 2026-03-31 | 2.37 |
| 2025-12-31 | 2.13 |
| 2025-09-30 | 2.45 |
| 2025-06-30 | 1.50 |
| 2025-03-31 | 2.24 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.01 |
| 2024-06-30 | 0.01 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.06 |
| 2023-09-30 | 0.05 |
| 2023-06-30 | 0.01 |
| 2023-03-31 | 0.03 |
| 2022-12-31 | 0.02 |
| 2022-09-30 | 0.01 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.05 |
| 2021-12-31 | 0.03 |
| 2021-09-30 | 0.02 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.01 |
| 2020-12-31 | 0.01 |
| 2020-09-30 | 0.02 |
| 2020-06-30 | 0.02 |
| 2020-03-31 | 0.01 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.03 |
| 2019-06-30 | 0.02 |
| 2019-03-31 | 0.07 |
| 2018-12-31 | 0.08 |
| 2018-09-30 | 0.01 |
| 2018-06-30 | 0.01 |
| 2018-03-31 | 0.01 |
| 2017-12-31 | 0.02 |
| 2017-09-30 | 0.02 |
| 2017-06-30 | 0.01 |
| 2017-03-31 | 0.01 |
| 2016-12-31 | 0.03 |
| 2016-09-30 | 0.08 |
| 2016-06-30 | 0.12 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
